While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.
Shkreli, a former pharmaceutical executive known for raising the price of a life-saving drug by 5,000%, was sentenced to seven years in prison for securities fraud in 2018.
